Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet specific alloantigens.

G L Davis1

  • 1Michigan State University, East Lansing 48823, USA.

Clinical Laboratory Science : Journal of the American Society for Medical Technology
|May 27, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European survey on the current surveillance practices, management guidelines, treatment pathways and heterogeneity of testing of Clostridioides difficile, 2018-2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI).

The Journal of hospital infection·2022
Same author

Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial.

Journal of viral hepatitis·2014
Same author

Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppression.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

Radium content of ultramafic igneous rocks; laboratory investigation.

American journal of science·2010
Same author

Planning the hospital for community service.

Minnesota medicine·2010
Same journal

Evaluation of Diverse Health Professionals' Learning Experience in a Continuing Education Activity for Quality Practices in Molecular Genetic Testing.

Clinical laboratory science : journal of the American Society for Medical Technology·2019
Same journal

Guidelines for Initiating a Research Agenda: Research Design and Dissemination of Results.

Clinical laboratory science : journal of the American Society for Medical Technology·2015
Same journal

Guidelines for Initiating a Research Agenda: Topic Selection and Evidence of Impact.

Clinical laboratory science : journal of the American Society for Medical Technology·2015
Same journal

Autonomy and Privacy in Clinical Laboratory Science Policy and Practice.

Clinical laboratory science : journal of the American Society for Medical Technology·2015
Same journal

The Value of Clinical Laboratory Sciences Research.

Clinical laboratory science : journal of the American Society for Medical Technology·2015
Same journal

From Technical Assistants to Critical Thinkers: From World War II to 2014.

Clinical laboratory science : journal of the American Society for Medical Technology·2015
See all related articles

Immune thrombocytopenias involve platelet destruction due to antibodies. This study focuses on alloimmune thrombocytopenias, where alloantibodies target platelet-specific antigens, impacting hemostasis.

Area of Science:

  • Hematology
  • Immunology

Background:

  • Platelet aggregation is crucial for hemostasis.
  • Thrombocytopenia, often immune-mediated, leads to bleeding.
  • Immune thrombocytopenias include autoimmune, alloimmune, and drug-induced forms.

Purpose of the Study:

  • To focus on alloimmune thrombocytopenias caused by alloantibodies to platelet-specific antigens.
  • To highlight the clinical significance of platelet alloantigens in eliciting alloantibody production.

Main Methods:

  • Review of immune mechanisms leading to platelet destruction.
  • Classification of immune thrombocytopenias based on antibody type.
  • Focus on alloantibody formation against platelet-specific antigens.

Main Results:

Related Experiment Videos

  • Alloimmune thrombocytopenias arise from alloantibodies targeting platelet-specific antigens.
  • Platelet alloantigens are key inducers of alloantibody production.
  • Alloantigens (isoantigens) trigger alloantibody formation in individuals lacking them.

Conclusions:

  • Alloimmune thrombocytopenias are a significant subtype of immune thrombocytopenia.
  • Understanding platelet alloantigens is vital for managing alloimmune thrombocytopenias.
  • Alloantigen-antibody interactions are central to this condition.